Stewart-Morgan, Kathleen R. http://orcid.org/0000-0001-7570-6217
Requena, Cristina E. http://orcid.org/0000-0001-5239-9162
Flury, Valentin http://orcid.org/0000-0003-0476-4940
Du, Qian
Heckhausen, Zoe http://orcid.org/0000-0003-0085-2492
Hajkova, Petra http://orcid.org/0000-0003-4145-1468
Groth, Anja http://orcid.org/0000-0003-0577-1771
Article History
Received: 6 January 2022
Accepted: 10 November 2022
First Online: 12 January 2023
Competing interests
: A.G. is co-founder and chief scientific officer (CSO) of ANKRIN Therapeutics. The remaining authors declare no competing interests.